Pitolisant oral tablets ( DrugBank: Pitolisant )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
193	プラダー・ウィリ症候群	1

193. プラダー・ウィリ症候群

---

臨床試験数 : 111 /  薬物数 : 120 - (DrugBank : 30) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 103

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04257929 (ClinicalTrials.gov)	December 9, 2020	29/1/2020	A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension	A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension	Prader-Willi Syndrome	Drug: Pitolisant oral tablets;Drug: Placebo oral tablet	Harmony Biosciences, LLC	NULL	Recruiting	6 Years	65 Years	All	60	Phase 2	United States